Business Description
Pharmadrug Inc
NAICS : 325410
SIC : 3741
ISIN : CA5134413031
Total Employee Number:
9Compare
Compare
Traded in other countries / regions
PHRX.CanadaLMLLF.USAG11.Germany IPO Date
2012-02-06Description
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The company's operations comprise of the corporate division in Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | -1.72 | |||||
Debt-to-Equity | -1.03 | |||||
Debt-to-EBITDA | -14.64 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 74.3 | |||||
3-Year EPS without NRI Growth Rate | 53.6 | |||||
3-Year FCF Growth Rate | 71.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.82 | |||||
9-Day RSI | 45.19 | |||||
14-Day RSI | 47.19 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.2 | |||||
Quick Ratio | 0.2 | |||||
Cash Ratio | 0.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.7 | |||||
Shareholder Yield % | -10.86 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -72.15 | |||||
ROIC % | -11.08 | |||||
3-Year ROIIC % | -20.86 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -16.51 | |||||
EV-to-EBITDA | -24.16 | |||||
EV-to-FCF | -19.49 | |||||
Earnings Yield (Greenblatt) % | -6.06 | |||||
FCF Yield % | -10.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmadrug Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.004 | ||
| Beta | -7.5313 | ||
| 3-Year Sharpe Ratio | 0.94 | ||
| 3-Year Sortino Ratio | 5.82 | ||
| Volatility % | 915.9 | ||
| 14-Day RSI | 47.19 | ||
| 14-Day ATR (€) | 0.000037 | ||
| 20-Day SMA (€) | 0.0005 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (€) | 0.0005 - 0.0165 | ||
| Shares Outstanding (Mil) | 134.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmadrug Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmadrug Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.142857:1 Stock Split | 2023-10-24 | 0.00 (+0.00%) | ||
| 0.05:1 Stock Split | 2016-08-02 | 1.12 (+0.00%) |
Show
Entries
Pharmadrug Inc Frequently Asked Questions
What is Pharmadrug Inc(FRA:G11)'s stock price today?
The current price of FRA:G11 is €0.00. The 52 week high of FRA:G11 is €0.02 and 52 week low is €0.00.
When is next earnings date of Pharmadrug Inc(FRA:G11)?
The next earnings date of Pharmadrug Inc(FRA:G11) is .
Does Pharmadrug Inc(FRA:G11) pay dividends? If so, how much?
Pharmadrug Inc(FRA:G11) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pharmadrug Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers